Ahn Joong Kyong, Hwang Jiwon, Lee Mi Yeon, Kang Mira, Hwang Junghye, Koh Eun-Mi, Cha Hoon-Suk
Division of Rheumatology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181, Republic of Korea.
Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.
Ther Adv Musculoskelet Dis. 2021 Feb 24;13:1759720X21993253. doi: 10.1177/1759720X21993253. eCollection 2021.
The aim of this study was to examine the impact of fat mass alteration on serum uric acid (SUA) levels in apparently clinically healthy men.
We evaluated 27,387 men who consecutively underwent health check ups between 2015 and 2017. We assessed the likelihood of achieving a SUA level of <0.41 mmol/L and compared the SUA levels according to fat mass changes.
Compared with those without fat mass change (the reference group), the odds ratios (95% confidence interval) of achieving a SUA level of <0.41 mmol/L for fat mass decreases of ⩾2.5, 1.5-2.5, and 0.5-1.5 kg were 1.63 (1.45-1.82), 1.19 (1.06-1.34), and 1.07 (0.97-1.18), respectively, while those for a fat mass increase of ⩾2.5, 1.5-2.5, and 0.5-1.5 kg were 0.71 (0.64-0.78), 0.87 (0.79-0.97), and 0.95 (0.86-1.04), respectively. The corresponding beta-coefficients of SUA levels (mmol/L) were -0.26 [-0.29-(-0.23)], -0.12 [-0.16-(-0.09)], and -0.09 [-0.12-(-0.06)] for fat mass decreases of ⩾2.5, 1.5-2.5, and 0.5-1.5 kg, respectively. Every 1-kg fat mass reduction was associated with 9% increased odds of achieving the target SUA level. The multivariate SUA level difference per 1-kg fat mass gain was 2.97 µmol/L. Similar levels of association persisted among the prespecified subgroups.
We quantitatively demonstrated that fat mass reduction contributes to a clinically relevant decrease in SUA levels and a significant increase in the likelihood of achieving target SUA levels. Our findings may help to provide clear clinical guidance on fat mass alteration to reduce SUA levels in patients with hyperuricemia.
本研究旨在探讨明显临床健康男性体内脂肪量改变对血清尿酸(SUA)水平的影响。
我们评估了2015年至2017年间连续接受健康检查的27387名男性。我们评估了SUA水平达到<0.41 mmol/L的可能性,并根据脂肪量变化比较了SUA水平。
与无脂肪量变化者(参照组)相比,脂肪量减少≥2.5 kg、1.5 - 2.5 kg和0.5 - 1.5 kg时,SUA水平达到<0.41 mmol/L的优势比(95%置信区间)分别为1.63(1.45 - 1.82)、1.19(1.06 - 1.34)和1.07(0.97 - 1.18),而脂肪量增加≥2.5 kg、1.5 - 2.5 kg和0.5 - 1.5 kg时,优势比分别为0.71(0.64 - 0.78)、0.87(0.79 - 0.97)和0.95(0.86 - 1.04)。脂肪量减少≥2.5 kg、1.5 - 2.5 kg和0.5 - 1.5 kg时,SUA水平(mmol/L)相应的β系数分别为-0.26 [-0.29 - (-0.23)]、-0.12 [-0.16 - (-0.09)]和-0.09 [-0.12 - (-0.06)]。每减少1 kg脂肪量与达到目标SUA水平的几率增加9%相关。每增加1 kg脂肪量,多变量SUA水平差异为2.97 µmol/L。在预先设定的亚组中,相似的关联水平持续存在。
我们定量证明了脂肪量减少有助于临床上显著降低SUA水平,并显著增加达到目标SUA水平的可能性。我们的研究结果可能有助于为改变脂肪量以降低高尿酸血症患者的SUA水平提供明确的临床指导。